Evidence map›Paper›PMID 32541671›Full record

ArticleCell death & disease2020

Brd4 inhibition ameliorates Pyocyanin-mediated macrophage dysfunction via transcriptional repression of reactive oxygen and nitrogen free radical pathways.

Feimei Zhu, Feng Xiong, Jinchen He, Keyun Liu, Yuanyuan You, Qian Xu, Junming Miao, Yu Du, Lijuan Zhang, Hongyu Ren and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Cells · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Feimei Zhu *Department of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Feng Xiong *Department of Cardiology, The third People's Hospital of Chengdu, 610031, Chengdu, China.
Jinchen HeDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Keyun LiuDepartment of Physiology, School of Medicine, Hubei University for Nationalities, 445000, Enshi, China.
Yuanyuan YouDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Qian XuDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Junming MiaoDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Yu DuDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Lijuan ZhangDepartment of Cardiology, The third People's Hospital of Chengdu, 610031, Chengdu, China.
Hongyu RenDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Xiaoying WangDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Junli ChenDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Jingyu LiDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Shanze ChenDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Xiaokang LiuDepartment of Pharmacology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.
Ning HuangDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China. huangpanxiao@sina.com.
Yi WangDepartment of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China. wangyi83@scu.edu.cn.
West China Medical Center of Sichuan University · CNChengdu Third People's Hospital · CNHubei University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages play critical roles in the first-line immune defense against airway infections caused by Pseudomonas aeruginosa (PA). The redox-active phenazine-pyocyanin (PCN), as one of the most essential virulence factors, facilities PA-related infection via a wide spectrum of cellular oxidative damages. However, little is known for PCN cytotoxicity in macrophages. In this study, besides showing PCN-mediated reactive oxygen species (ROS) indeed involved in macrophage viability and function impairment, we at the first time demonstrated a novel role of reactive nitrogen species (RNS) pathway causing cellular damage in PCN-challenged macrophages. Using small molecule inhibitor JQ1 targeting Bromodomain and extra-terminal family proteins, we showed restrained iNOS-dependent nitric oxide (NO) production correlated with abolished Brd4 recruitment to the NOS2 (encoding inducible nitric oxide synthase-iNOS) promoter. Application of JQ1 diminished PCN-mediated peroxynitrite (ONOO

Indexed as

AnimalsBromodomain Containing ProteinsCell Cycle ProteinsFree RadicalsHumansMacrophagesMaleMiceNitrogenPyocyanineReactive Oxygen SpeciesTranscription FactorsBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsFree RadicalsNitrogenPyocyanineReactive Oxygen SpeciesTranscription Factors

Identifiers

PMID32541671
PMCPMC7295752
OpenAlexW3034561072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.